|
We don't own it... We help you sell it.
|
Login | Register |
|
The Medical Industry Business Weekly Now Updated Every Weekday |
| October 11, 2008 |
|
Other HeadlinesMicrobubbles loaded with chemo drugs find tumors and attack them.
Merge is first healthcare firm to join the SIIA in fight against software piracy.
Molecular CT adds metabolic information from PET to traditional CT and enables truly integrated diagnostic imaging for maximized workflow efficiency and quick return on investment.
The MIR (Management in Radiology) annual conference will be held in Vouliagmeni, Athens, Greece from Wednesday 29th until Friday 31st October 2008.
Society of Nuclear Medicine launches innovative process for integrating imaging biomarkers into phase 1, 2 and 3 pharmaceutical clinical trials.
Have News for Us?Submit your news on the industry, people, or companies.More People & Company HeadlinesMerge Healthcare Announces Authentic eFilm Software Merge is first healthcare firm to join the SIIA in fight against software piracy. Experimental Catheter Ablation Device Provides Tactile Feedback For the first time, physicians will be able to accurately measure the contact force between the catheter and the beating heart wall. HCP 2009 Spring & Fall Radiology and Imaging Conferences Health Connect Partners Conferences use a "Reverse EXPO" concept, which has helped them become very popular. Alliance Medical Acquires Tomovation Major European deal sealed this week. Dr. Michael Friebe, CEO of Tomovation GmbH, will be appointed as Managing Director of Alliance Medical GmbH. Get a FREE LISTING in DOTmed's 2009 Buyer's Guide Go to the link inside this story and get a Free Listing with just a few clicks! CT and MRI Imaging Expert Launches LG Medical Technologies, Inc. Jim Gallagher creates new company. R2 Quantra Receives FDA Approval Hologic has received FDA clearance for a new breast density assessment tool that provides radiologists with an automated method for assessing breast density. McCain vs. Obama: Tell Us Your Views How will the U.S. healthcare system be affected by the next president? Advanced New LA County-USC Trauma Center Redefines Resuscitation Through Integrating Mounted Point-Of-Care Ultrasound 12 SonoSite S-FAST ultrasound tools mounted on resuscitation towers alongside monitors, defibrillators, and pulse oximeters. Luna Innovations Receives Funding for Brain Cancer Diagnostic Agent Using Nanotechnology Luna developing improved MRI agent to detect, diagnose and treat brain cancers. Vascular Solutions CEO Elected to MDMA Board of Directorsby Barbara Kram, Editor
Washington, D.C. - The Medical Device Manufacturers Association (MDMA), a national trade association based in Washington D.C., welcomed Howard Root to the Board of Directors at the MDMA Annual Meeting held in Washington in June.
"I am honored to serve on the Board of the Medical Device Manufacturers Association," stated Root. "MDMA has a long history of advocating on behalf of entrepreneurial medical technology companies to promote innovation and enhance patient care." MDMA's Executive Director, Mark Leahey stated, "MDMA's Board of Directors has historically reflected the ideals of the innovative, entrepreneurial companies that comprise our membership and Howard is no exception." Leahey went on to say, "the Association remains committed to achieving legislative and regulatory policies necessary to ensure the research-based entrepreneurial sector of the medical device industry continues to flourish." Other board members include; Wayne Barlow of Wescor, Inc.; Wil Boren of Biomet, Inc.; Nancy Briefs of Eleme, Inc.; Chris Chavez of Advanced Neuromodulation Systems (ANS); Kelvyn Cullimore, Jr. of Dynatronics Corporation; Ryan Drant of New Enterprise Associates; Brad Gary of Allergan, Inc.; Ken Hayes of Biomerix Corporation; Eamonn Hobbs of AngioDynamics, Inc.; Joe Kiani of Masimo Corporation; Alex Lukianov of NuVasive, Inc.; Casey McGlynn of Wilson Sonsini Goodrich & Rosati; Guy Nohra of Alta Partners; Jo Ellen Slurzberg of Almyra, Inc.; Mark Sieczkerek of Conceptus, Inc.; Thomas Thompson of Neuro Resource Group (NRG); Paul Touhey of Fujirebio Diagnostics, Inc.; Russ Trenary of Advanced Medical Optics (AMO) and Mark Wan of Three Arch Partners. As founder of Vascular Solutions in 1997, Root led the company since inception; including taking the company public in 2000. Over the last five years, he has guided Vascular Solutions in the development and launching of over 30 new devices for the diagnosis and treatment of vascular conditions, resulting in over $50 million in annual sales and profitability. Previously, Mr. Root was Vice President of ATS Medical, Inc. and practiced corporate law at the law firm of Dorsey & Whitney The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C., representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
Please Send us your Comments. |